Literature DB >> 23585934

Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option.

Shahzad G Raja1.   

Abstract

Entities:  

Year:  2013        PMID: 23585934      PMCID: PMC3621921          DOI: 10.3978/j.issn.2072-1439.2013.02.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  5 in total

Review 1.  Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.

Authors:  Shahzad G Raja
Journal:  Cardiovasc Ther       Date:  2010-10       Impact factor: 3.023

Review 2.  Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.

Authors:  Shahzad G Raja; Mark D Danton; Kenneth J MacArthur; James C Pollock
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-04-05       Impact factor: 2.628

Review 3.  Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.

Authors:  Shahzad G Raja
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2012-08

4.  Treating pulmonary arterial hypertension: current treatments and future prospects.

Authors:  Shahzad G Raja; Shahbaz M Raja
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

Review 5.  Sildenafil: emerging cardiovascular indications.

Authors:  Shahzad G Raja; Suneela H Nayak
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

  5 in total
  1 in total

1.  Sodium tanshinone IIA silate as an add-on therapy in patients with unstable angina pectoris.

Authors:  Haiyan Zhang; Mingzhi Long; Zhiwen Wu; Xu Han; Yichao Yu
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.